142 related articles for article (PubMed ID: 21038308)
1. Intravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental model.
Johnsen-Soriano S; Arnal E; Sancho-Tello M; Muriach M; Almansa I; Bosch-Morell F; Navea A; Romero FJ
Eur J Ophthalmol; 2011; 21(4):427-33. PubMed ID: 21038308
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.
Roh MI; Kim HS; Song JH; Lim JB; Kwon OW
Ophthalmology; 2009 Jan; 116(1):80-6. PubMed ID: 19118699
[TBL] [Abstract][Full Text] [Related]
3. Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.
Agawa T; Usui Y; Wakabayashi Y; Okunuki Y; Juan M; Umazume K; Kezuka T; Takeuchi M; Yamauchi Y; Goto H
Retina; 2014 Sep; 34(9):1811-8. PubMed ID: 24801651
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation.
Lafreniere JD; Toguri JT; Gupta RR; Samad A; O'Brien DM; Dickinson J; Cruess A; Kelly MEM; Seamone ME
Clin Exp Ophthalmol; 2019 Jul; 47(5):638-645. PubMed ID: 30485637
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.
Matsuyama K; Ogata N; Matsuoka M; Wada M; Nishimura T; Takahashi K
J Ocul Pharmacol Ther; 2011 Aug; 27(4):379-83. PubMed ID: 21810018
[TBL] [Abstract][Full Text] [Related]
6. A comparison of intravitreal bevacizumab and steroid activity in an experimental uveitis model.
Ayyıldız O; Durukan AH; Ozgurtas T; Gunal A
Curr Eye Res; 2015; 40(12):1261-8. PubMed ID: 25546479
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab.
Funk M; Schmidinger G; Maar N; Bolz M; Benesch T; Zlabinger GJ; Schmidt-Erfurth UM
Retina; 2010 Oct; 30(9):1412-9. PubMed ID: 20711086
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection.
Ohira S; Inoue T; Shobayashi K; Iwao K; Fukushima M; Tanihara H
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3541-8. PubMed ID: 26030108
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor.
Nishida T; Miyata S; Itoh Y; Mizuki N; Ohgami K; Shiratori K; Ilieva IB; Ohno S; Taylor AW
Int Immunopharmacol; 2004 Aug; 4(8):1059-66. PubMed ID: 15222980
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
Lim JW
Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
[TBL] [Abstract][Full Text] [Related]
12. Acute intraocular inflammation following intravitreal injection of bevacizumab--a large cluster of cases.
Fielden M; Nelson B; Kherani A
Acta Ophthalmol; 2011 Dec; 89(8):e664-5. PubMed ID: 21159147
[No Abstract] [Full Text] [Related]
13. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
14. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans.
Meyer CH; Krohne TU; Holz FG
Acta Ophthalmol; 2012 Feb; 90(1):68-70. PubMed ID: 20163369
[TBL] [Abstract][Full Text] [Related]
16. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats.
Lemaitre C; Thillaye-Goldenberg B; Naud MC; de Kozak Y
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2022-30. PubMed ID: 11481267
[TBL] [Abstract][Full Text] [Related]
17. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
Zhou M; Chen S; Wang W; Huang W; Cheng B; Ding X; Zhang X
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3874-9. PubMed ID: 23674760
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment.
Kaneda S; Miyazaki D; Sasaki S; Yakura K; Terasaka Y; Miyake K; Ikeda Y; Funakoshi T; Baba T; Yamasaki A; Inoue Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2982-8. PubMed ID: 21273540
[TBL] [Abstract][Full Text] [Related]
19. Cytokine levels of the aqueous humour in central serous chorioretinopathy.
Jung SH; Kim KA; Sohn SW; Yang SJ
Clin Exp Optom; 2014 May; 97(3):264-9. PubMed ID: 24417755
[TBL] [Abstract][Full Text] [Related]
20. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
Nonobe NI; Kachi S; Kondo M; Takai Y; Takemoto K; Nakayama A; Hayakawa M; Terasaki H
Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
